A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease

NCT07252440 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

AD
Early Alzheimer's Disease

Interventions

DRUG: TTYP01 tables 60mg
DRUG: TTYP01 tables 90mg
DRUG: TTYP01 tables 0mg

Sponsor

Shanghai Auzone Biological Technology Co., Ltd.